This single-operator phantom study demonstrates the technical feasibility of colocating a live bronchoscope video stream with patient-specific 3D airway models on Apple Vision Pro using a native Network Device Interface pipeline, without establishing comparative or clinical benefit.

Lower Austria is scaling its cancer care network to address rising diagnoses and an aging population under the new Health Plan 2040+.

Canadian medical professionals have developed a novel two-step procedure that could significantly improve outcomes for patients with atrial fibrillation (AFib), a common heart rhythm disorder. The innovative approach, pioneered by Dr. Paul Angaran and Dr. Gianluigi Bisleri at St. Michael's Hospital in Toronto, combines robotic surgery with catheter ablation techniques to address the limitations of current treatments. AFib, which affects 1-2% of the general population, causes irregular heartbeats that can lead to serious complications including stroke and heart failure. Current standard treatments typically involve either medication or catheter ablation, where doctors create scar tissue in the heart to block irregular electrical signals. However, these methods often prove ineffective for patients with long-standing persistent AFib. The new procedure involves first using robotic technology to create external scars on the heart, followed by a catheter-based technique to treat internal areas. This dual approach allows for more comprehensive treatment of the heart's electrical pathways. Dr. Bisleri explained that the robotic component provides greater precision and access to the heart, while the catheter technique targets specific internal areas. The treatment has shown promising results, with potential success rates of 70-80% for patients with long-standing persistent AFib. One of the first patients to undergo the procedure was Jon Davies from Edmonton, who had been diagnosed with AFib and had previously been told surgery wasn't an option due to his enlarged heart. After learning about the new procedure online, Davies underwent the first part of the treatment in September and is scheduled for the second phase in the coming weeks. He expressed optimism about the potential to move beyond the 'status quo' of lifelong blood thinner medication. The doctors noted that while the procedure is a Canadian first, awareness remains limited, and patients must be referred to their specialized team. The treatment requires a few weeks or months between procedures to allow for healing of the external scars before proceeding with the internal catheter ablation. This advancement represents a significant step forward in cardiac care for AFib patients, offering hope for improved quality of life and reduced risk of complications.

New breakthrough in protein research: Scientists at KAIST identified PROX1 as the protein that blocks our retina from healing. By neutralizing it, mouse retinas started regenerating naturally and rest...

**Gene Solutions Unveils Real-World Evidence in Prenatal and Women’s Genomic Health at ISPD 2026 Conference** At the recent International Society for Prenatal Diagnosis (ISPD) 2026…

The new op-termin.wien platform has scheduled over 245 hip and knee surgeries since May, reducing wait times for patients in Vienna.

🌍 HEALTHCARE DOESN’T NEED ANOTHER TEMPORARY FIX — IT NEEDS STRUCTURAL CHANGE.HUMAN SAFETY BEGINS WITH STRONGER HEALTHCARE SYSTEMS.Every day, hospitals, medical professionals, and healthcare institutio...

🌍 HEALTHCARE DOESN’T NEED ANOTHER TEMPORARY FIX — IT NEEDS STRUCTURAL CHANGE.HUMAN SAFETY BEGINS WITH STRONGER HEALTHCARE SYSTEMS.Every day, hospitals, medical professionals, and healthcare institutio...

Visit showcases how Niowave’s advanced manufacturing workforce is leading the next generation of scientific innovation and cancer treatment. LANSING, Mich., Oct. 16, 2026 /PRNewswire/ — Yesterday, Niowave welcomed Labor Secretary Keith Sonderling for a tour of the company’s operations and a first-hand look at progress on the construction of its new medical radioisotope production facility. Secretary Sonderling toured Niowave’s current dedicated production facility as well as the construction site for its second, and held a roundtable with Niowave leaders, who detailed the company’s production of medical radioisotopes for next-generation cancer treatments. Discussions also covered how the new facility will expand […]

유전성 안질환인 슈타가르트병으로 중심 시력을 잃어가는 환자에게 시력 회복용 칩 PRIMA가 처음 이식됐다는 소식이 전해졌습니다. Science Corporation은 호주 시드니 안과 병원에서 진행 중인 임상시험의 일환으로 지난 5월 첫 슈타가르트병 환자에게 PRIMA를 이식했으며,

A new adult retina repair study shows how one-time gene therapy restored retinal function in dogs. Learn what it means for future vision loss treatment.

Optimismo que nos une

🇬🇧 A Nottingham-developed MRI test can identify multiple sclerosis without a lumbar puncture, shortening diagnosis and reducing the need for an invasive procedure.

Explore the potential of AI-designed medicine in slowing Cellular Aging. Discover how Cellular Aging research could revolutionize future treatments.

Zehair Ayub had been living with arteriovenous malformation (AVM), a condition that causes an abnormal tangle of blood vessels in the brain, since 2011. He had exhausted all viable treatment options…

The Accela radiotherapy solution is engineered around NeoArc dynamic modulated arc therapy (DMAT),  a breakthrough technique combining speed and precision. NeoArc makes single breath-hold stereotactic...